Biotech Stock News (INO) (NYMX)

Inovio Pharmaceuticals (NASDAQ:INO) On Monday June 20, 2016 Inovio Pharmaceuticals along with one of its subsidiaries Gene One Life Sciences have received authorization from the FDA to begin a first ever trial in humans targeting the Zika Virus. This is a monumental event, because it will the first trial ever to begin treating humans with … Read more